NCT07493525

Brief Summary

This cross-sectional observational study aims to determine the frequency of falls in patients with myotonic dystrophy type 1 and to identify factors affecting dynamic balance. The study will also evaluate fear of falling, selected lower extremity muscle strength, and the relationship between muscle strength and fall frequency. The findings may contribute to a better understanding of fall risk and balance impairment in patients with myotonic dystrophy type 1.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
41

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 20, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2025

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

March 20, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 25, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2026

Completed
Last Updated

March 25, 2026

Status Verified

March 1, 2026

Enrollment Period

4 months

First QC Date

March 20, 2026

Last Update Submit

March 20, 2026

Conditions

Keywords

dynamic balancefallsfall frequencyfear of fallingmuscle strenghtneuromuscular diseasepostural controlgaitbalance impairmentrehabilitation

Outcome Measures

Primary Outcomes (1)

  • Fall frequency

    Fall frequency will be assessed using semi-structured questions regarding the number of falls experienced by patients with myotonic dystrophy type 1.

    At baseline

Secondary Outcomes (8)

  • Fear of falling

    At baseline

  • Muscular Impairment Rating Scale score

    At baseline

  • Dynamic balance performance by Timed Up and Go test

    At baseline

  • Walking performance by 10-Meter Walk Test at maximum safe speed

    At baseline

  • Isometric muscle strength

    At baseline

  • +3 more secondary outcomes

Study Arms (1)

Myotonic Dystrophy Type 1 Group

Patients with myotonic dystrophy type 1 who are evaluated for fall frequency, dynamic balance, fear of falling, and lower extremity muscle strength.

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

The study population will consist of adult patients with myotonic dystrophy type 1 who are followed at the Neuromuscular Diseases Center of Antalya Training and Research Hospital. Participants who meet the predefined eligibility criteria and are able to complete the balance, mobility, and muscle strength assessments will be included.

You may qualify if:

  • Adults aged between 18 and 60 years old
  • Diagnosis of myotonic dystrophy type 1
  • Ability to understand and follow study instructions
  • Ability to ambulate, with or without an assistive device, sufficiently to perform the study assessments
  • Willingness to participate and provide written informed consent

You may not qualify if:

  • Severe cognitive impairment interfering with understanding or completion of the study assessments
  • Severe visual impairment interfering with balance and mobility testing
  • Severe sensory impairment, including markedly impaired vibration sensation, that may affect balance assessment
  • Any additional neurological, musculoskeletal, vestibular, or other medical condition that could substantially affect gait, balance, or fall risk independently of myotonic dystrophy type 1
  • Acute medical condition or unstable clinical status at the time of assessment
  • Inability to complete the study evaluations

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Antalya Training and Research Hospital

Antalya, Antalya, 07100, Turkey (Türkiye)

Location

Related Publications (11)

  • Berends J, Tieleman AA, Horlings CGC, Smulders FHP, Voermans NC, van Engelen BGM, Raaphorst J. High incidence of falls in patients with myotonic dystrophy type 1 and 2: A prospective study. Neuromuscul Disord. 2019 Oct;29(10):758-765. doi: 10.1016/j.nmd.2019.08.012. Epub 2019 Aug 28.

    PMID: 31540818BACKGROUND
  • Hammaren E, Kjellby-Wendt G, Kowalski J, Lindberg C. Factors of importance for dynamic balance impairment and frequency of falls in individuals with myotonic dystrophy type 1 - a cross-sectional study - including reference values of Timed Up & Go, 10m walk and step test. Neuromuscul Disord. 2014 Mar;24(3):207-15. doi: 10.1016/j.nmd.2013.12.003. Epub 2013 Dec 15.

    PMID: 24412157BACKGROUND
  • Jimenez-Moreno AC, Raaphorst J, Babacic H, Wood L, van Engelen B, Lochmuller H, Schoser B, Wenninger S. Falls and resulting fractures in Myotonic Dystrophy: Results from a multinational retrospective survey. Neuromuscul Disord. 2018 Mar;28(3):229-235. doi: 10.1016/j.nmd.2017.12.010. Epub 2017 Dec 27.

    PMID: 29361394BACKGROUND
  • Wiles CM, Busse ME, Sampson CM, Rogers MT, Fenton-May J, van Deursen R. Falls and stumbles in myotonic dystrophy. J Neurol Neurosurg Psychiatry. 2006 Mar;77(3):393-6. doi: 10.1136/jnnp.2005.066258. Epub 2005 Sep 30.

    PMID: 16199443BACKGROUND
  • Pieterse AJ, Luttikhold TB, de Laat K, Bloem BR, van Engelen BG, Munneke M. Falls in patients with neuromuscular disorders. J Neurol Sci. 2006 Dec 21;251(1-2):87-90. doi: 10.1016/j.jns.2006.09.008. Epub 2006 Nov 9.

    PMID: 17097113BACKGROUND
  • Schoene D, Heller C, Aung YN, Sieber CC, Kemmler W, Freiberger E. A systematic review on the influence of fear of falling on quality of life in older people: is there a role for falls? Clin Interv Aging. 2019 Apr 24;14:701-719. doi: 10.2147/CIA.S197857. eCollection 2019.

    PMID: 31190764BACKGROUND
  • Trombetti A, Reid KF, Hars M, Herrmann FR, Pasha E, Phillips EM, Fielding RA. Age-associated declines in muscle mass, strength, power, and physical performance: impact on fear of falling and quality of life. Osteoporos Int. 2016 Feb;27(2):463-71. doi: 10.1007/s00198-015-3236-5. Epub 2015 Jul 21.

    PMID: 26194491BACKGROUND
  • Kierkegaard M, Petitclerc E, Hebert LJ, Mathieu J, Gagnon C. Responsiveness of performance-based outcome measures for mobility, balance, muscle strength and manual dexterity in adults with myotonic dystrophy type 1. J Rehabil Med. 2018 Feb 28;50(3):269-277. doi: 10.2340/16501977-2304.

    PMID: 29260836BACKGROUND
  • Hammaren E, Kollen L. What Happened with Muscle Force, Dynamic Stability And Falls? A 10-Year Longitudinal Follow-Up in Adults with Myotonic Dystrophy Type 1. J Neuromuscul Dis. 2021;8(6):1007-1016. doi: 10.3233/JND-200521.

    PMID: 34151851BACKGROUND
  • Hammaren E, Kjellby-Wendt G, Lindberg C. Muscle force, balance and falls in muscular impaired individuals with myotonic dystrophy type 1: a five-year prospective cohort study. Neuromuscul Disord. 2015 Feb;25(2):141-8. doi: 10.1016/j.nmd.2014.11.004. Epub 2014 Nov 13.

    PMID: 25475393BACKGROUND
  • Bachasson D, Moraux A, Ollivier G, Decostre V, Ledoux I, Gidaro T, Servais L, Behin A, Stojkovic T, Hebert LJ, Puymirat J, Eymard B, Bassez G, Hogrel JY. Relationship between muscle impairments, postural stability, and gait parameters assessed with lower-trunk accelerometry in myotonic dystrophy type 1. Neuromuscul Disord. 2016 Jul;26(7):428-35. doi: 10.1016/j.nmd.2016.05.009. Epub 2016 May 12.

    PMID: 27234310BACKGROUND

MeSH Terms

Conditions

Myotonic DystrophyNeuromuscular Diseases

Condition Hierarchy (Ancestors)

Muscular DystrophiesMuscular Disorders, AtrophicMuscular DiseasesMusculoskeletal DiseasesMyotonic DisordersHeredodegenerative Disorders, Nervous SystemNeurodegenerative DiseasesNervous System DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Hanife Hale Hekim, MD

    Antalya Training and Research Hospital

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident Physician

Study Record Dates

First Submitted

March 20, 2026

First Posted

March 25, 2026

Study Start

June 20, 2025

Primary Completion

October 15, 2025

Study Completion

June 15, 2026

Last Updated

March 25, 2026

Record last verified: 2026-03

Locations